Clinical Trials Browser

Phase 1 × Hydroxyurea × 90 days × Clear all

NCT06063317 2026-03-06

OASIS

Phase 1 Terminated

Bites and Stings

NCT06871410 2026-01-26

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute